Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Neo-Green Pharmaceutical is a prominent Chinese enterprise specializing in the research, development, production, and distribution of Traditional Chinese Medicine (TCM) formula granules. The company is one of the few entities authorized by the Chinese government to manufacture TCM granules, operating a comprehensive industrial chain that spans from standardized herbal cultivation to high-tech extraction. Neo-Green is widely recognized for its "Smart TCM Pharmacy" system, an automated dispensing technology that streamlines the prescription process in hospitals. Headquartered in Chengdu, the company integrates modern pharmaceutical standards with traditional medicine to ensure product consistency and safety. Their portfolio includes hundreds of varieties of TCM granules used across a broad spectrum of therapeutic areas in clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Neo-Green TCM.